Autolus Therapeutics plc
AUTL- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- SEC CIK
- 0001730463
In the last 90 days, Autolus Therapeutics plc insiders filed 0 open-market purchases and 1 sale; 83 institutions reported holding it in 13F filings for Q2 2026, worth $212.0M in total; no superinvestor holds it.
Q2 2026 vs. Q1 2026
How the institutions holding Autolus Therapeutics plc changed between Q1 2026 and Q2 2026.
All holders in Q2 2026All holders in Q1 2026
| Measure | Q1 2026 | Q2 2026 | Change |
|---|---|---|---|
| Holders | 84 | 83 | −1 |
| Shares | 134.4M | 132.2M | −2.23M (−1.7%) |
| Value | $184.4M | $212.0M | +$27.6M (+15.0%) |
New holders (9)
Institutions that held Autolus Therapeutics plc at the end of Q2 2026 but not at the end of Q1 2026.
| Institution | Shares | Value | % of portfolio |
|---|---|---|---|
| HRT Financial LP | 89,363 | $142.0K | 0.00% |
| Virtu Financial LLC | 23,557 | $38.0K | 0.00% |
| Quantum Financial Partners LLC | 18,795 | $30.1K | 0.02% |
| Aigen Investment Management, LP | 17,837 | $28.5K | 0.01% |
| StoneX Group Inc. | 16,965 | $27.3K | 0.00% |
| Lido Advisors, LLC | 15,509 | $24.8K | 0.00% |
| Blair William & Co | 15,000 | $24.0K | 0.00% |
| Northwestern Mutual Wealth Management Co | 3,700 | $5.92K | 0.00% |
| Quarry LP | 1,581 | $2.53K | 0.00% |
Sold out (10)
Institutions that held Autolus Therapeutics plc at the end of Q1 2026 and filed for Q2 2026 without it.
| Institution | Shares, Q1 2026 | Value, Q1 2026 |
|---|---|---|
| Diametric Capital, LP | 178,731 | $246.6K |
| Aubrey Capital Management Ltd | 130,000 | $180.1K |
| Aquatic Capital Management LLC | 114,398 | $157.9K |
| SG Americas Securities, LLC | 66,107 | $91.0K |
| Tudor Investment Corp Et Al | 46,213 | $63.8K |
| Two Sigma Securities, LLC | 43,462 | $60.0K |
| Prelude Capital Management, LLC | 27,200 | $37.5K |
| Simplex Trading, LLC | 23,641 | $32.6K |
| Icon Wealth Advisors, LLC | 15,000 | $21.1K |
| MAI Capital Management | 189 | $261 |